company background image
A064550 logo

Bioneer KOSDAQ:A064550 Stock Report

Last Price

₩32.75k

Market Cap

₩845.3b

7D

-7.0%

1Y

-16.5%

Updated

16 Aug, 2024

Data

Company Financials +

Bioneer Corporation

KOSDAQ:A064550 Stock Report

Market Cap: ₩845.3b

A064550 Stock Overview

Operates as a biotechnology company in South Korea, the Americas, Europe, Asia, Africa, and internationally.

A064550 fundamental analysis
Snowflake Score
Valuation5/6
Future Growth6/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Bioneer Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Bioneer
Historical stock prices
Current Share Price₩32,750.00
52 Week High₩44,350.00
52 Week Low₩23,950.00
Beta-1.07
11 Month Change-8.01%
3 Month Change4.47%
1 Year Change-16.45%
33 Year Change-41.52%
5 Year Change396.21%
Change since IPO135.61%

Recent News & Updates

Bioneer Corporation's (KOSDAQ:064550) Share Price Boosted 25% But Its Business Prospects Need A Lift Too

Jul 11
Bioneer Corporation's (KOSDAQ:064550) Share Price Boosted 25% But Its Business Prospects Need A Lift Too

Lacklustre Performance Is Driving Bioneer Corporation's (KOSDAQ:064550) Low P/S

Mar 06
Lacklustre Performance Is Driving Bioneer Corporation's (KOSDAQ:064550) Low P/S

Recent updates

Bioneer Corporation's (KOSDAQ:064550) Share Price Boosted 25% But Its Business Prospects Need A Lift Too

Jul 11
Bioneer Corporation's (KOSDAQ:064550) Share Price Boosted 25% But Its Business Prospects Need A Lift Too

Lacklustre Performance Is Driving Bioneer Corporation's (KOSDAQ:064550) Low P/S

Mar 06
Lacklustre Performance Is Driving Bioneer Corporation's (KOSDAQ:064550) Low P/S

Bioneer (KOSDAQ:064550) Seems To Use Debt Quite Sensibly

Mar 25
Bioneer (KOSDAQ:064550) Seems To Use Debt Quite Sensibly

Bioneer Corporation's (KOSDAQ:064550) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Feb 15
Bioneer Corporation's (KOSDAQ:064550) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Investors Who Bought Bioneer (KOSDAQ:064550) Shares A Year Ago Are Now Up 166%

Jan 20
Investors Who Bought Bioneer (KOSDAQ:064550) Shares A Year Ago Are Now Up 166%

Is Bioneer (KOSDAQ:064550) A Risky Investment?

Dec 24
Is Bioneer (KOSDAQ:064550) A Risky Investment?

Here's Why We Think Bioneer's (KOSDAQ:064550) Statutory Earnings Might Be Conservative

Nov 28
Here's Why We Think Bioneer's (KOSDAQ:064550) Statutory Earnings Might Be Conservative

Shareholder Returns

A064550KR BiotechsKR Market
7D-7.0%1.3%4.1%
1Y-16.5%35.8%5.2%

Return vs Industry: A064550 underperformed the KR Biotechs industry which returned 34.4% over the past year.

Return vs Market: A064550 underperformed the KR Market which returned 2.5% over the past year.

Price Volatility

Is A064550's price volatile compared to industry and market?
A064550 volatility
A064550 Average Weekly Movement11.8%
Biotechs Industry Average Movement9.5%
Market Average Movement6.5%
10% most volatile stocks in KR Market12.0%
10% least volatile stocks in KR Market3.4%

Stable Share Price: A064550 has not had significant price volatility in the past 3 months.

Volatility Over Time: A064550's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of KR stocks.

About the Company

FoundedEmployeesCEOWebsite
1992574Han-Oh Parkwww.bioneer.co.kr

Bioneer Corporation operates as a biotechnology company in South Korea, the Americas, Europe, Asia, Africa, and internationally. The company offers PCR and RT-PCR, real-time PCR, RNAi, chemicals, plastic consumables, and buffer and solutions; and sample preparation, protein synthesis and purification, gene cloning, fluorescence dye and quencher, electrophoresis, genome-wide function, and magnetic separation services, as well as instruments for conventional PCR, real-time PCR, sample preparation, protein synthesis, centrifuge and vortex mixer, and electrophoresis. It also provides molecular diagnosis, including MDx technologies, human diagnostics kits, MDx extraction kits, and instruments; and products for animal, aquatic-bio, mosquito-borne, and plant diseases, as well as food safety, human pathogen, and nano-bio products.

Bioneer Corporation Fundamentals Summary

How do Bioneer's earnings and revenue compare to its market cap?
A064550 fundamental statistics
Market cap₩845.29b
Earnings (TTM)-₩10.95b
Revenue (TTM)₩286.42b

3.0x

P/S Ratio

-77.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A064550 income statement (TTM)
Revenue₩286.42b
Cost of Revenue₩64.25b
Gross Profit₩222.17b
Other Expenses₩233.12b
Earnings-₩10.95b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-424.15
Gross Margin77.57%
Net Profit Margin-3.82%
Debt/Equity Ratio22.4%

How did A064550 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.